MA25501A1 - Traitement de l'endometriosis ou de la sterilite ou amelioration de la fertilite. - Google Patents

Traitement de l'endometriosis ou de la sterilite ou amelioration de la fertilite.

Info

Publication number
MA25501A1
MA25501A1 MA26584A MA26584A MA25501A1 MA 25501 A1 MA25501 A1 MA 25501A1 MA 26584 A MA26584 A MA 26584A MA 26584 A MA26584 A MA 26584A MA 25501 A1 MA25501 A1 MA 25501A1
Authority
MA
Morocco
Prior art keywords
endometriosis
fertility
sterility
improvement
treatment
Prior art date
Application number
MA26584A
Other languages
English (en)
French (fr)
Inventor
William J Bologna
Howard L Levine
Dominique De Ziegler
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Publication of MA25501A1 publication Critical patent/MA25501A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MA26584A 1999-10-05 2002-04-04 Traitement de l'endometriosis ou de la sterilite ou amelioration de la fertilite. MA25501A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15775499P 1999-10-05 1999-10-05
US66838400A 2000-09-25 2000-09-25

Publications (1)

Publication Number Publication Date
MA25501A1 true MA25501A1 (fr) 2002-07-01

Family

ID=26854456

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26584A MA25501A1 (fr) 1999-10-05 2002-04-04 Traitement de l'endometriosis ou de la sterilite ou amelioration de la fertilite.

Country Status (28)

Country Link
EP (1) EP1220667B1 (enExample)
JP (2) JP2003510354A (enExample)
KR (1) KR100738724B1 (enExample)
CN (1) CN1218694C (enExample)
AR (1) AR028487A1 (enExample)
AT (1) ATE271860T1 (enExample)
AU (1) AU780736B2 (enExample)
BR (1) BR0014548A (enExample)
CA (1) CA2385974C (enExample)
CO (1) CO5251423A1 (enExample)
DE (1) DE60012554T2 (enExample)
DK (1) DK1220667T3 (enExample)
ES (1) ES2223581T3 (enExample)
GE (1) GEP20043313B (enExample)
HK (1) HK1044120B (enExample)
HU (1) HU225990B1 (enExample)
IL (2) IL148784A0 (enExample)
MA (1) MA25501A1 (enExample)
MX (1) MXPA02003453A (enExample)
MY (1) MY129518A (enExample)
NO (1) NO329663B1 (enExample)
NZ (1) NZ518429A (enExample)
PE (1) PE20010742A1 (enExample)
PT (1) PT1220667E (enExample)
TR (1) TR200200899T2 (enExample)
TW (1) TWI280877B (enExample)
UA (1) UA74168C2 (enExample)
WO (1) WO2001024788A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
EP1872775A1 (en) 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
CN102906103A (zh) * 2010-03-22 2013-01-30 利普生物药剂公司 用于抗孕酮的非毒性递送的组合物和方法
KR101010031B1 (ko) * 2010-12-08 2011-01-21 류상범 흡수식 냉온수기용 엘리미네이터
MX363640B (es) 2012-05-31 2019-03-28 Repros Therapeutics Inc Formulaciones y metodos para la administracion vaginal de antiprogestinas.
US9545411B2 (en) 2012-11-02 2017-01-17 Repros Therapeutics Inc. Methods and compositions for treating progesterone-dependent conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241087A (en) * 1979-04-02 1980-12-23 William H. Rorer, Inc. Dysmenorrhea treatment
NZ232801A (en) * 1989-03-07 1992-01-29 Adeza Biomedical Corp Diagnostic test for endometriosis
JP2602456B2 (ja) * 1990-04-12 1997-04-23 雪印乳業株式会社 子宮内膜症治療剤
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
NO20021591D0 (no) 2002-04-04
MXPA02003453A (es) 2002-08-20
AR028487A1 (es) 2003-05-14
DK1220667T3 (da) 2004-12-06
EP1220667A2 (en) 2002-07-10
NO20021591L (no) 2002-05-28
WO2001024788A2 (en) 2001-04-12
AU780736B2 (en) 2005-04-14
WO2001024788A3 (en) 2001-12-06
BR0014548A (pt) 2002-06-04
MY129518A (en) 2007-04-30
HUP0203050A3 (en) 2006-02-28
CA2385974A1 (en) 2001-04-12
HK1044120A1 (en) 2002-10-11
CA2385974C (en) 2010-01-26
JP2003510354A (ja) 2003-03-18
PT1220667E (pt) 2004-11-30
ATE271860T1 (de) 2004-08-15
IL148784A (en) 2006-12-31
CN1377264A (zh) 2002-10-30
DE60012554T2 (de) 2005-11-24
KR20020062285A (ko) 2002-07-25
ES2223581T3 (es) 2005-03-01
NZ518429A (en) 2004-02-27
DE60012554D1 (de) 2004-09-02
GEP20043313B (en) 2004-03-10
HK1044120B (en) 2004-12-17
NO329663B1 (no) 2010-11-29
TWI280877B (en) 2007-05-11
KR100738724B1 (ko) 2007-07-12
AU7525000A (en) 2001-05-10
JP2010018639A (ja) 2010-01-28
UA74168C2 (uk) 2005-11-15
PE20010742A1 (es) 2001-07-19
CO5251423A1 (es) 2003-02-28
IL148784A0 (en) 2002-09-12
HU225990B1 (en) 2008-02-28
EP1220667B1 (en) 2004-07-28
TR200200899T2 (tr) 2002-07-22
CN1218694C (zh) 2005-09-14
HUP0203050A2 (hu) 2003-02-28

Similar Documents

Publication Publication Date Title
CH1143977H1 (fr) 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite
CY2018020I1 (el) Θεραπεια της νοσου ρομρε
PT1233973E (pt) Derivados de adenosina n6-heterociclicos 5'-tio-substituida agonistas parciais ou totais de a1
DZ1877A1 (fr) Forme posologiques d'azithromycine pour le traitement d'infection microbiennes.
MA26207A1 (fr) Compositions de traitement de l'eau.
DE60023043D1 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
DZ2396A1 (fr) Traitement de l'eau
MA25411A1 (fr) Microorganismes attenues pour le traitement d'infection.
EP1390029A4 (en) PHENYLINDOLE FOR THE TREATMENT OF HIV
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
MA26896A1 (fr) Utilisation de compositions d'antibiotiques azalides pour le traitement ou la prevention d'une infection par des bacteries ou protozoaires chez des mammiferes
MA25501A1 (fr) Traitement de l'endometriosis ou de la sterilite ou amelioration de la fertilite.
MA26289A1 (fr) Faible concentration de peroxyde pour le traitement ou la prevention d'infections vaginales
DE69711649D1 (de) P1, p4-dithio-p2,p3-monochloromethylen 5',5'''-diadenosin-p1,p4-tetraphosphat verwendet als anti-thrombose mittel
EP1126850A4 (en) TREATMENT OF RETINAL DISEASES
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DZ1988A1 (fr) Thérapie de combinaison pour le traitement de l'hiv.
BR0012921A (pt) Compostos calcilìticos
RU97115190A (ru) Антисептическое средство для обработки воды
MY124071A (en) Treatment of viral disease in swine
DZ3320A1 (fr) Complexe comprenant de l'eletriptane et de la sulphobutylether-cyclodextrine pour le traitement de la migraine
FR2698102B1 (fr) Composition destinée au lavage de la peau ou des muqueuses.
EP0981545A4 (en) TREATMENT OF OSTEOPOROSIS
EP1157694A4 (en) REMEDIES OF THE ERECTIONAL DISORDER